In a recent newspaper interview, Christian Krätzig, President of H&T Presspart, explains why true partnership today begins well before production. Instead of traditional contract manufacturing, H&T Presspart relies on integrated teams, shared roadmaps, and continuous exchange — from the first device idea through to highly automated series production. Insights from early project phases are purposefully fed into later series realities, creating speed, clarity, and reliability.

Partnership means thinking together, planning transparently, and sharing responsibility across the entire lifecycle. H&T Presspart combines system expertise from primary packaging to the device, ensures low-friction transitions between development, verification, and industrialization, and keeps the focus on what matters to customers: getting to market faster, ensuring stable series production, and securing a robust supply chain in the background.

At the same time, H&T Presspart looks ahead: solutions for new therapy forms, digitally enabled quality and automation, resilient “local for local” structures in Europe and the United States, and sustainability that is built in from the start. Collaboration as equals thus creates room for customers to focus on their core tasks — while H&T Presspart takes on scaling to series production and reliably accompanies the journey.

Read the full interview: Partnerschaft in der Pharmaindustrie | Fokus Online